Gene Patents Invalid in Early Action, But Game Far From Over

By: Lisa Treannie

A federal judge in NY struck a blow to gene patents and methods of genetic analysis in this week’s ruling in Association for Molecular Pathology and ACLU v. USPTO and Myriad (S.D.N.Y. 2010). Should the decision be upheld on appeal, it will have far reaching consequences, affecting thousands of issued patents and the business model of the industry.

Click here to read more.